Status:

COMPLETED

Lifestyle Modification and Blood Pressure Study

Lead Sponsor:

University of Pennsylvania

Conditions:

High Blood Pressure

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to compare the effects of 24 weeks of either a blood pressure education and walking program versus a yoga exercise program versus the combined intervention of blood pressu...

Detailed Description

The study is a non-blinded, randomized controlled trial to assess the safety and efficacy of 24 weeks of a structured yoga exercise program (YP) versus a blood pressure education and walking program (...

Eligibility Criteria

Inclusion

  • Subjects must be willing and able to give written informed consent.
  • Age \> 18 years, but \< 75 years.
  • BP criteria: Systolic Blood Pressure (SBP) of \> 130, but \< 160 mm Hg.
  • Willing to comply with all study-related procedures.

Exclusion

  • Subjects who are pregnant or post partum \< 3 months.
  • Subjects currently taking BP lowering medications or dietary supplements (magnesium, potassium, calcium \> 1200 mg/day, fish oils, ephedra, hawthorn, forskolin, etc…).
  • Stage II HTN (SBP \> 160 mmHg OR diastolic blood pressure (DBP) \> 100 mmHg).
  • Non-dominant arm circumference \> 50 cm.
  • BMI \> 40.0 kg/m2.
  • Practicing yoga \>1x/month in the previous 6 months.
  • Received/used experimental drug or device within 30 days prior to screening, or donated blood \> 1 pint within 8 weeks of screening.
  • Diabetes mellitis.
  • Established cardiovascular disease.
  • Known arrhythmias or cardiac pacemakers.
  • Current users (within 30 days) of any tobacco products.
  • History of renal insufficiency (glomerular filtration rate \< 60 ml/min).
  • Women consuming \> 7 alcoholic drinks/week; men consuming \> 14 drinks/week.
  • Known autonomic neuropathy.
  • Known secondary cause of HTN (renal artery stenosis, pheochromocytoma, coarctation of aorta, hyperaldosteronism).
  • Benzodiazepine, anti-psychotic drugs (3 month stable use of SSRIs are allowed), or steroid use.
  • Known severe musculoskeletal problems such as spinal stenosis that may limit participation in yoga.
  • Use of other mind/ body therapies such as Qi Gong, Tai Chi, meditation.
  • Lack Internet access.
  • Presence of non-removable metallic foreign object, surgically implanted electrical device, surgically placed metallic clip (aneurysm clip), ear implants, any history of metal implants in the eye.

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2015

Estimated Enrollment :

147 Patients enrolled

Trial Details

Trial ID

NCT00964847

Start Date

August 1 2009

End Date

June 1 2015

Last Update

February 15 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital at the University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104